engleski

Medullary breast cancer heterogeneity: an immunohistochemical analysis of ER, PR and HER-2 expression

Recent publications of breast cancer classification based on gene expression profile analyses indicate thatmedullary breast carcinomas (MBC)may be considered part of the basal-like carcinoma spectrum made up of ER-negative, PR-negative and HER-2-negative cells (“ triple-negative phenotype” )..... The data from our study seem to be generally comparable with the relatively scarce published data on clinicopathological parameters of MBC and AMBC.

breast cancer ; ER ; PR ; HER-2

nije evidentirano